$CRD Picked up a starting position a couple weeks back in advance of AGM, added a bit more yesterday after positive update. Haven’t seen much chatter so quick background: US consumer finance marketplace (scalable Platform business) which links millennial consumers with lenders. $CRD Started in student loans (US$20B market), then added personal loans ($150B) and credit cards. Recently entered the enormous US ($1.6T) mortgage market - a small % share there would move the needle.

$NXS Next Science lists shortly. Its Xbio technology targets biofilm-protected bacteria (apparently 90% of all bacteria including serious threats Golden Staph and e.Coli). Biofilm shields bacteria and builds resistance to antibiotics etc. $NXS 4 products have been approved by the FDA and launched into the US market, first 2 in 2017. Recently signed distribution partners should significantly expand reach for these 2 and should reduce S&M costs vs historical levels.

Ecofibre $EOF listing shortly at 11am. Have a starting position (scaled back 50%). Not sure how useful this will be - expect to be pretty illiquid given only $20M raised, new shares representing just 6% of total, and something like 65% of previous shares escrowed for 2 years /1 $EOF But quick thoughts anyway. The comparison will be inevitably made with $EXL and there are some similarities - though EOF brings exposure to hemp-based textiles, and doesn’t (yet) have a focus on medicinal cannabis /2